During this episode of Biotalk, Geoff Meyerson, CEO of Locust Walk, unpacks our 2024 Q3 Report: Global Trends in Biopharma Transactions Report.Each quarter, Locust Walks deal team compiles key stati

On this episode of Biotalk, Locust WalksAndy MeyersonwelcomesDr. Lindsay Rosenwald, Chairman, President and Chief Executive Officer ofFortress Biotech, a company focused on licensing and developi

On this episode of Biotalk, Locust WalksGeoff MeyersonwelcomesStephen Sands, former Vice Chairman of Investment Banking and Chairman of the Global Healthcare Group, and currently Senior Advisor at

During this episode of Biotalk,Geoff Meyerson, CEO ofLocust Walk, unpacks our2024 Q1 Report: Global Trends in Biopharma Transactions Report.Each quarter, Locust Walks deal team compiles key stati

In this episode, Geoff provides valuable insights into our report, focusing on critical areas such as: Biotech capital markets: XBI performance and IPO volume Private biotech markets: Financing

On this episode of Biotalk,Locust WalksGeoff MeyersonwelcomesSoufiane Aboulhouda, Co-Founder and Chairman of the Board ofNucleate, a global non-profit dedicated to empowering future biotech lead

On this episode of Biotalk,Locust WalksDaniel Brogwelcomes withShehnaaz Suliman, M.D., CEO ofReCode Therapeutics, a clinical-stage genetic medicines company using its selective organ targeting l

On this episode of Biotalk,Locust WalksGeoff MeyersonwelcomesErrik Anderson, CEO and Founder ofAlloy Therapeutics, to the podcast. Alloy is a trailblazing drug-discovery company, bringing collab